Orion Portfolio Solutions, LLC Biocryst Pharmaceuticals Inc Transaction History

Orion Portfolio Solutions, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$14.21 - $17.65 $168,587 - $209,399	-11,864 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$9.5 - $17.24 $110,200 - $199,983	-11,600 Reduced 49.44%	11,864 $188,000
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $20,400 - $37,672	2,768 Added 13.37%	23,464 $239,000
Q4 2020 Feb 04, 2021	BUY	$3.37 - $8.61 $2,342 - $5,983	695 Added 3.47%	20,696 $154,000
Q3 2020 Nov 13, 2020	BUY	$3.43 - $5.53 $68,603 - $110,605	20,001 New	20,001 $69,000
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $160 - $411	-100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $159 - $345	100 New	100 $0

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.